Scrip's 2010 Pharma League Tables – Top companies force growth in a pressure cooker environment
This article was originally published in Scrip
Loss of patent protection, the weaker economy, increased competition from generic products and pricing pressures have produced an environment of constant challenges for the pharma industry. Nevertheless, most of the leading companies in Scrip Intelligence's Pharma League Tables for 2009 found ways to expand in an industry that underwent major restructuring, says IBI principal analyst Ashley Yeo.
You may also be interested in...
Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”
The EU Partnership on Health Innovation, a new public private health care research partnership, is in the final drafting phase before its launch under Horizon Europe. In Vivo asked the partnership’s medtech industry lead, Patrick Boisseau, to set out the innovation challenges for participants as they address unmet health care needs in Europe.
Chinese monitoring of the spread of COVID-19 locally has reported no new cases of home-grown infection in a single day for the first time since the outbreak began. It indicates control efforts, including the NMPA’s fast-tracking of relevant devices, PPE and IVDs, are having the desired effects.